Capecitabine (Capecitabine Tablets) — Patient-Friendly Guide

Capecitabine is an oral anticancer medicine used to treat several types of cancer. It belongs to a group of medicines called antimetabolites (specifically, pyrimidine analogues). Capecitabine is designed to work in the body by converting into its active form, which then helps slow or stop cancer cell growth.

This guide explains how capecitabine works, how it is used, what to expect, common side effects, and practical tips for safer use—tailored for people in Australia.

Basic Product Information

• Generic name: Capecitabine
• Common brand names (examples): Xeloda and others (brand availability may vary)
• Dosage form: Oral tablets
• Medicine class: Antineoplastic (anticancer) / antimetabolite
• How it’s supplied: Usually as tablet strengths (commonly 150 mg and 500 mg in many markets)
• Typical use: Used alone or with other anticancer medicines depending on cancer type and treatment plan

Note: Tablet strengths and the exact schedule can vary by condition, body size, and treatment regimen.

How Capecitabine Works (Mechanism of Action)

Capecitabine is a “prodrug”, meaning it is converted in the body into the active medicine that fights cancer.

Once taken, capecitabine is metabolised in a step-by-step process, ultimately producing 5-fluorouracil (5-FU) within tissues. This active form interferes with how cells make DNA and RNA:

• Inhibits thymidylate synthase, an enzyme needed to make DNA building blocks
• Disrupts nucleic acid synthesis, which can slow tumour cell growth and lead to cell death

Capecitabine’s design helps target activity more toward tumour tissue than some older chemotherapy approaches, although it can still affect healthy cells—especially those that divide quickly (such as skin, gut lining, and blood cells).

Pharmacokinetics (How the Body Handles Capecitabine)

Pharmacokinetics describes how a medicine moves through the body—absorption, metabolism, distribution, and elimination.

• Absorption: Capecitabine is taken by mouth and is absorbed from the gastrointestinal tract.
• Activation and metabolism: It is metabolised through several steps in the body, including conversion to 5-FU in tissues.
• Active metabolites: The anticancer activity is related to the formation of 5-FU and related metabolites.
• Elimination: Most metabolites are eliminated primarily through the kidneys (urine).
• Effect of kidney function: Because elimination involves kidney pathways, kidney impairment may increase exposure and may require dose adjustment and closer monitoring.

Because capecitabine metabolism and elimination depend partly on kidney function and liver metabolism, dosing is commonly individualised.

Typical Uses and Indications

Capecitabine is used for certain cancers, including (depending on local clinical guidelines and treatment protocol):

• Breast cancer: Often used in metastatic settings or in combination regimens as determined by oncology teams
• Colorectal cancer: Commonly used for metastatic colorectal cancer and sometimes in adjuvant or neoadjuvant contexts
• Gastric (stomach) or gastro-oesophageal cancers: In specific combinations where appropriate
• Other solid tumours: In some settings based on specialist decision-making

Important: The exact indication, regimen, and cycle length depend on the cancer type, stage, prior treatments, and overall health. Always follow the oncology team’s plan.

How to Take Capecitabine (Timing and Practical Use)

Capecitabine is usually taken in courses/cycles. A common schedule is based on taking tablets twice daily for a defined period followed by a rest period. The exact number of days “on” treatment and “off” treatment varies by regimen.

General timing guidance

• Twice daily dosing: Typically taken about 12 hours apart.
• Consistency: Try to take doses at similar times each day.
• Do not double up: If you miss a dose, follow the advice provided by your treatment team or pharmacist.

Swallowing instructions

• Swallow tablets whole with water.
• Do not crush or chew unless your healthcare professional advises otherwise.
• Keep tablets in their original packaging and store them as directed on the label.

Missed dose (general approach)

Whether you should skip a missed dose or take it later depends on timing and regimen. For safe use, contact your pharmacist/oncology team for guidance rather than guessing.

Food Interactions (Eating With Capecitabine)

Food can significantly affect capecitabine absorption and the amount of medicine available for action.

• Recommended: Capecitabine is generally taken after food (often after breakfast and after dinner) to reduce gastrointestinal side effects and improve tolerability.
• Avoid taking on an empty stomach: Taking without food may increase the risk of nausea, diarrhoea, and other side effects for some people.

Practical tip: Plan your dose around meals. If your appetite is low, discuss options with your oncology team—e.g., small meals or nutritional strategies—rather than skipping doses.

Alcohol and Medicine Interactions

Alcohol does not directly “cancel out” capecitabine in the way some medicines do, but it can increase certain risks while you are on treatment—particularly if you are prone to nausea, diarrhoea, dehydration, or liver stress.

• Alcohol use: Consider limiting or avoiding alcohol during treatment unless your clinician says it’s acceptable.
• Dehydration risk: Both alcohol and chemotherapy can contribute to dehydration—especially if you develop diarrhoea.
• Fatigue and sedation: Alcohol may worsen treatment-related tiredness and reduce your ability to manage daily medication.
• Drug interactions: Alcohol can interact indirectly by affecting the metabolism of other medicines you may be taking.

Common medicine interaction considerations

Capecitabine can interact with several medicines. Tell your pharmacist or oncology team about all medicines you take, including:

• Warfarin or other blood thinners (may affect clotting control)
• Allopurinol (used for gout) and related medicines
• Folic acid or vitamin supplements (may influence toxicity in combination settings)
• Antacids or acid-reducing medicines (may affect absorption depending on product and timing)
• Leucovorin (folinic acid) when used with capecitabine regimens
• Phenytoin and some seizure medicines

Because interaction risk depends on your full regimen and medical history, it’s important not to add or stop medicines on your own.

Safety Profile: What to Expect

Capecitabine can cause side effects. Some are predictable and manageable, while others require urgent attention. Your oncology team may prescribe supportive medicines (for example, anti-nausea medicines) and schedule blood tests to monitor safety.

Common side effects

• Diarrhoea (sometimes severe—prompt treatment matters)
• Nausea or vomiting
• Loss of appetite
• Fatigue and weakness
• Hand-and-foot syndrome (palmar-plantar erythrodysesthesia): redness, swelling, pain, or peeling of skin on hands/feet
• Mouth sores (stomatitis)
• Abdominal discomfort
• Skin changes
• Low blood counts (may lead to infection risk and anaemia)

Less common but serious side effects (seek prompt medical help)

• Severe diarrhoea or dehydration symptoms (dizziness, reduced urine, fainting)
• Fever or signs of infection (for example, temperature above your clinician’s threshold)
• Severe mouth ulcers preventing fluids/food
• Uncontrolled bleeding or unusual bruising (possible blood count issues)
• Allergic reactions (swelling, rash with breathing difficulty)
• Chest pain, severe shortness of breath, or sudden neurological symptoms

If you experience symptoms that feel severe, rapidly worsening, or unexpected, contact your treatment team urgently.

Practical Use Tips (How to Stay Safer at Home)

1) Support your gut and hydration

• Drink fluids regularly, especially if diarrhoea occurs.
• Use oral rehydration solutions if recommended.
• Follow dietary advice given by your oncology team for diarrhoea management.

2) Prevent and manage hand-and-foot syndrome

• Keep hands and feet moisturised with a bland emollient.
• Avoid heat exposure to hands/feet (hot showers, hot water bottles).
• Reduce friction and pressure (comfortable shoes, cushioned insoles).
• Notify your team early if redness, tingling, pain, or swelling begins.

3) Protect your mouth

• Use gentle mouth care (soft toothbrush, bland rinses).
• Avoid mouth irritants (alcohol-based mouthwash, spicy foods) if they worsen soreness.
• Report mouth ulcers early for supportive treatment.

4) Don’t ignore blood test schedules

Monitoring is central to safe use. Blood tests may be required regularly to check blood counts, kidney function, and overall tolerance. Keep appointments even if you feel well.

5) Travel, work, and daily routine

• Plan dosing around meals and your schedule.
• Carry a list of your medicines and your oncology contact details.
• Arrange extra support during days you typically feel more unwell.

Dosing: How It Is Determined

Dose is individualised based on factors such as:

• Body surface area (BSA) (calculated from height and weight)
• Renal (kidney) function
• Age and overall performance status
• Whether capecitabine is used alone or in combination
• Previous treatment tolerance and side effect history

Typical regimens vary by indication. Many schedules involve taking capecitabine twice daily for a set number of days followed by a rest period, then repeating cycles.

Important: Dosing instructions on your prescription label (or treatment plan paperwork) must be followed exactly. Tablet counts may change with your regimen and dose adjustments.

Kidney and Liver Considerations

Because capecitabine is eliminated largely via the kidneys, kidney impairment may require dose reduction or increased monitoring. Some liver function abnormalities may also affect how treatment is tolerated.

• Tell your clinician about any history of kidney disease, dialysis, or transplant.
• Inform them about liver disease, hepatitis, or regular liver test abnormalities.

Safety: Warnings and Monitoring

Capecitabine requires close monitoring during treatment. Key safety steps include:

• Regular blood tests to monitor blood counts and organ function
• Early reporting of diarrhoea, mouth sores, fever, and hand-and-foot symptoms
• Dose adjustments if side effects occur (your oncology team may pause treatment temporarily or reduce doses)

Do not change your schedule without medical guidance.

Alternative Options

Alternative cancer treatments depend on the specific cancer type, stage, genetics, and prior therapies. Depending on circumstances, clinicians may consider:

• Infusional 5-fluorouracil (5-FU) or other chemotherapy protocols
• Capecitabine-like oral or related regimens in certain cancers (as determined by oncology teams)
• Targeted therapies (for example, based on tumour markers)
• Immunotherapy for suitable cancers
• Surgery and/or radiotherapy in curative settings

Your oncology team can discuss what options are most suitable for you, including why capecitabine may be chosen (or not chosen) in your situation.

Market and Legal Context in Australia

In Australia, capecitabine is an established anticancer medicine used across public and private healthcare settings. Access can involve specialist oversight and monitoring as part of structured cancer care.

In general:

• Prescription and supervision: Anticancer medicines are regulated and are typically supplied under medical direction with appropriate monitoring.
• Safety monitoring requirements: Treatment requires planned review, blood tests, and management of side effects.
• Supply continuity: Availability may depend on stock levels and pharmacy supply chains.

If you have questions about eligibility, supply processes, or local availability, consult your treating team or a pharmacist.

Recent Guidance and Treatment Approach Updates (General Notes)

Oncology practice evolves with new evidence, and dosing schedules can be updated based on outcomes and safety data. In recent years, the emphasis has increasingly been on:

• Early symptom management (especially diarrhoea and hand-and-foot syndrome)
• Personalised dosing based on kidney function and tolerability
• Supportive medicines such as anti-nausea therapy and treatments for diarrhoea prevention/management where appropriate
• Clinical monitoring using blood tests and toxicity grading tools

For the most up-to-date regimen details, always refer to your specialist team’s current plan and supportive care instructions.

Delivery, Availability, and Storage

Availability

Capecitabine availability in Australia can vary by:

• Strengths and pack sizes
• Local pharmacy stock levels
• Supplier lead times

Delivery

Online pharmacy delivery typically follows standard logistics (with packaging designed to protect tablets). Delivery time depends on your location and the pharmacy’s courier network.

Storage

• Store tablets according to the label instructions (commonly at controlled room temperature).
• Keep out of reach of children.
• Store in original packaging to protect from moisture and maintain correct identification.

If you notice tablets are damaged, discoloured, or the packaging is compromised, speak with your pharmacist before using.

Side Effects Summary Table

FAQ About Capecitabine (Australia)

1) What is capecitabine used for?

Capecitabine is an oral chemotherapy medicine used for certain cancers such as colorectal and breast cancer, and sometimes gastric or gastro-oesophageal cancers, depending on the treatment plan.

2) How should I take capecitabine—before or after food?

Capecitabine is generally taken after food to improve tolerance and reduce gastrointestinal side effects. Follow your exact regimen instructions provided by your treatment team or pharmacist.

3) What does “twice daily” mean?

It usually means you take a dose in the morning and another dose in the evening, approximately 12 hours apart. Keep the times consistent to maintain steady exposure.

4) Can I drink alcohol while taking capecitabine?

It’s often recommended to limit or avoid alcohol during treatment, mainly because of dehydration risk, nausea, and overall tolerance. Ask your clinician if small amounts are acceptable for your situation.

5) What happens if I miss a dose?

Whether to skip or take a missed dose depends on your timing and regimen. Contact your pharmacist or oncology team for specific guidance rather than guessing.

6) How long does a treatment cycle last?

Cycles vary by regimen and indication. Many schedules include a period of daily twice-daily dosing followed by a rest period, then repeating. Your treatment plan will specify exact dates.

7) What should I do if I develop diarrhoea?

Diarrhoea should be managed promptly. Contact your oncology team early for advice. Severe diarrhoea can become dangerous due to dehydration and electrolyte imbalance.

8) What is hand-and-foot syndrome and how can I reduce it?

Hand-and-foot syndrome is a common capecitabine-related reaction affecting palms and soles, causing redness, pain, tingling, or peeling. Moisturising, avoiding heat/pressure, comfortable footwear, and early reporting are key.

9) Are there drug interactions with common medicines?

Yes. Capecitabine can interact with medicines such as blood thinners (e.g., warfarin), gout medicines, and others. Always provide your full list of medicines (including supplements and herbal products) to your pharmacist.

10) How is kidney function relevant to capecitabine?

Capecitabine is largely eliminated through the kidneys. If kidney function is reduced, medicine exposure may increase, so dose adjustments and closer monitoring may be needed.

11) Is capecitabine available in Australia?

Capecitabine is generally available through Australian pharmacy supply chains, but specific strengths and pack sizes can vary. Delivery time may depend on stock and courier options.

When to Contact Your Healthcare Team

Contact your treating team promptly if you experience:

• Fever or signs of infection
• Severe or persistent diarrhoea
• Signs of dehydration (dizziness, very low urine, fainting)
• Severe mouth ulcers
• Severe hand-and-foot symptoms or skin breakdown
• Allergic symptoms such as swelling or breathing difficulty

Early communication helps prevent complications and may allow timely dose adjustments.

Important Reminder

This information is designed to help you understand capecitabine in a general, patient-friendly way. Your personal treatment plan—including your dose, cycle schedule, and monitoring—must be determined by your oncology team based on your condition and health status. If you have any questions about your tablets, side effects, or how to take them with meals, your pharmacist is also a valuable source of support.